Zepbound vs Wegovy is the comparison most people researching weight-loss medication eventually land on, because these are the two drugs built specifically for weight management. They are easy to confuse, but unlike Ozempic and Wegovy, they are not the same drug.
This guide breaks down how Zepbound and Wegovy actually compare on weight loss, how they work, what they cost, and which differences matter when you are deciding with a prescriber. The short version: both work well, one has an edge in head-to-head testing, and the gap has narrowed in 2026.
Zepbound vs Wegovy: Two Different Drugs, One Goal
The first thing to understand is that Zepbound and Wegovy are different medications.
Zepbound contains tirzepatide, and Wegovy contains semaglutide. Both are FDA approved for chronic weight management in adults with obesity, or with overweight plus a weight-related condition, but they are distinct molecules.
This is the opposite of Ozempic vs Wegovy, where both products are the same drug. Here, you are genuinely choosing between two different medicines. It is also the obesity-brand version of the Ozempic vs Mounjaro comparison, since Mounjaro and Zepbound are both tirzepatide, and Ozempic and Wegovy are both semaglutide.
Zepbound vs Wegovy for Weight Loss: What the Trials Show
The clearest evidence comes from SURMOUNT-5, the first head-to-head trial between the two.
In that study, Zepbound produced 20.2% average body weight loss compared to 13.7% for Wegovy over 72 weeks, according to Eli Lilly’s published results and independent reporting on the trial. That is a meaningful margin, and it made Zepbound the stronger performer at standard doses.
The story changed in 2026. Novo Nordisk introduced Wegovy HD, a higher 7.2 mg dose of semaglutide, and newer comparisons show it performing at or slightly above Zepbound on weight loss. So Zepbound has the edge at the doses used in SURMOUNT-5, but at the top end the two are now closer than the original trial suggested.
Zepbound vs Wegovy at a Glance
| Feature | Zepbound | Wegovy |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Drug class | Dual GIP and GLP-1 agonist | GLP-1 agonist |
| FDA approved for | Weight management; obstructive sleep apnea | Weight management; heart risk; fatty liver (MASH) |
| Average weight loss (head-to-head) | 20.2% (SURMOUNT-5) | 13.7% at 2.4 mg; about 21% at 7.2 mg “HD” |
| Maximum dose | 15 mg per week | 2.4 mg per week (7.2 mg “HD” in 2026) |
| Available forms | Injection (pen and vials) | Injection plus an oral pill (2025) |
| List price per month, no insurance | About $1,000 to $1,086 | About $1,349 |
How They Work
The difference in results traces back to how each drug works.
Wegovy (semaglutide) activates one receptor, GLP-1, which reduces appetite and slows how fast the stomach empties. Zepbound (tirzepatide) activates two receptors, GIP and GLP-1, at the same time.
That dual action is the leading explanation for why tirzepatide tends to produce more weight loss than semaglutide at standard doses. Both, though, work on the same basic principle: less hunger, smaller portions, and steadier blood sugar.
Beyond Weight: Other FDA Approvals
If you have a health condition beyond weight, the approvals can tip the decision.
Zepbound is also FDA approved to treat obstructive sleep apnea in adults with obesity, which is a meaningful edge if sleep apnea is part of your picture.
Wegovy is approved to reduce the risk of major cardiovascular events in adults with overweight or obesity, and it is also approved for a form of fatty liver disease known as MASH. So Wegovy carries the stronger heart and liver story, while Zepbound carries the sleep apnea approval.
Cost and Insurance
Cost is close on paper but varies a lot in practice.
Without insurance, Zepbound lists around $1,000 to $1,086 per month and Wegovy around $1,349. Both Eli Lilly and Novo Nordisk now sell lower-cost single-dose vials or self-pay subscriptions directly, which can bring the cash price down considerably.
Insurance coverage for weight-loss drugs is inconsistent and often requires prior authorization for either one. For the full breakdown of pricing and savings programs, see our cost without insurance guide.
Side Effects
The side effect profiles are similar.
In SURMOUNT-5, the most common side effects for both drugs were gastrointestinal, including nausea, diarrhea, constipation, and vomiting, and they were generally mild to moderate. Most people find these ease as the dose is raised slowly over time.
Serious side effects were uncommon in the trial and were not significantly different between the two medications.
Can You Switch, or Take Both?
Two common questions, with clear answers.
You should not take Zepbound and Wegovy together. They work on overlapping pathways, so combining them adds risk without a proven benefit.
Switching between them is possible and fairly common, usually when one drug stalls or causes side effects that are hard to tolerate. Because the dosing scales are different, the switch is guided by your prescriber, who will usually restart you at a low dose of the new drug and titrate up.
Protecting Your Muscle on Either Drug
Whichever you choose, the same trade-off applies. Rapid weight loss on these medications includes lean muscle, not just fat, and research suggests a meaningful share of the weight lost can come from muscle.
That is why protein and resistance training matter so much on either drug. We break down the exact targets in our Ozempic muscle loss guide and what to eat on a GLP-1. Protecting muscle is what turns weight loss into the right kind of weight loss.
The Bottom Line
Zepbound and Wegovy are both strong, FDA-approved weight-loss drugs, but they are different medicines. Zepbound (tirzepatide) led the head-to-head SURMOUNT-5 trial with 20.2% weight loss versus 13.7%, though Wegovy’s higher-dose HD version has closed much of that gap in 2026. Zepbound adds a sleep apnea approval, while Wegovy adds heart and liver approvals and an oral pill option.
For most people, the better choice comes down to which one your insurance covers, which side effects you tolerate, and which extra health benefits matter for you. Make that call with a qualified healthcare provider, and remember that the medication is only half the plan. For the same-drug comparison, see Ozempic vs Wegovy, and for the diabetes-brand version, see Ozempic vs Mounjaro.